09:01:49 EDT Thu 29 Oct 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Shell Summary for March 23, 2020

2020-03-23 20:23 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell 5.35 points to 351.19 Monday. Eva Koci's first capital pool shell, Klinik Health Ventures Corp. (KHV: halted), plans to acquire 2576560 Ontario Inc., doing business as NeuPath Health, for the shell's qualifying transaction. The shell will roll back 1 for 5, leaving it with 3,869,500 shares issued, then issue 24,187,055 shares to its target's shareholders.

NeuPath was formed in 2017 in Toronto. It has since acquired two chains of chronic pain management clinics in Southern Ontario. First, there is InMedic Creative Medicine, which has three clinics. According to InMedic's website, its treatments include nerve blocks (anesthesia), lidocaine infusion (also anesthesia), medication and counselling. Second, there is CPM or Centres for Pain Management with nine clinics. Some of CPM's treatments are free, for instance, a six-week/12-hour group counselling program. According to CPM's website, most of its paid treatments are covered by the Ontario Health Insurance Plan. Among the potential exceptions are rehabilitation services for patients between the ages of 20 and 64. Neither CPM nor InMedic mentions marijuana treatments on its website, but in the QT news release, NeuPath does. There are no details yet about the marijuana treatments. NeuPath also mentions meditation programs.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2020 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.